At the injection site, CFA-driven innate immune activation releases inflammatory mediators that lower the activation threshold of nociceptors, the sensory neurons that detect potentially damaging stimuli. This peripheral sensitization can amplify incoming signals before they reach the central nervous system. The model therefore links local immune activity with measurable changes in pain-related behavior and sensory processing.
Peripheral inflammation can influence more than local tissue. In CFA-treated rats, altered nociceptive input provides a way to examine how inflammatory signals affect spinal and brain mechanisms involved in pain. This is especially useful for studying neuroimmune signaling, in which immune activity and neural processing interact, rather than treating pain as an exclusively neuronal event.
Because the inflammatory response develops over a defined period, investigators can relate behavioral or neural changes to the progression of inflammation. This temporal structure helps separate early effects associated with peripheral immune activation from later changes in sensory or central pain processing. It also supports assessment of whether a treatment changes the course or consequences of inflammation.
CFA-treated rats can reveal both overt pain-related behaviors and heightened sensory responsiveness. Examining these outcomes together helps distinguish a general change in pain-related behavior from increased sensitivity to sensory stimulation. When paired with neural analyses, the model can connect observable behavior with altered processing in pathways spanning peripheral nerves, spinal mechanisms, and the brain.
Researchers select CFA-treated rats when they need a controlled inflammatory-pain context for testing analgesic or anti-inflammatory treatments. Drug effects can be evaluated against the model’s inflammation-associated behavioral and sensory changes, while neural measurements can indicate whether an intervention influences peripheral sensitization, neuroimmune signaling, or pain-related processing in the spinal cord and brain.
In neuroscience, this model helps trace how a peripheral inflammatory event can reshape pain processing across levels of the nervous system. Studies may use it to connect local mediator release and nociceptor sensitization with downstream spinal and brain responses. That multilevel perspective supports research on pain pathways and mechanisms underlying sensory hypersensitivity after inflammation.